NEOMED is committed to the Ohio IP Promise
Fostering technology commercialization & entrepreneurship
Research discoveries at NEOMED are actively commercialized with the support of The REDIzone to connect life science entrepreneurs with our research faculty. Additionally, The REDIzone is driving our industry collaborations to leverage NEOMED’s vast research infrastructure and expertise to solve commercially challenging problems.
At NEOMED, we are committed to The Ohio IP Promise. This initiative fosters a climate where innovation thrives through partnerships among universities, researchers, entrepreneurs, investors and industry. With improved collaboration, high-impact discoveries made at Ohio universities will go to market more quickly, boosting Ohio’s economy and improving its residents’ lives with new products and services.
Discover how NEOMED is Driving Economic Growth
Innovation & Research at NEOMED
-
Read moreWhat can the powerful leaps of today’s lemurs and marmosets tell us about how early primates evolved? Jesse Young, Ph.D., […]
-
Read moreAs a second-year College of Medicine student, how do you choose a specialty when you’re torn between family medicine, psychiatry […]
-
Read moreMerri Rosen, Ph.D., director of Hearing Research at Northeast Ohio Medical University, has been awarded a 5-year, $2.3 million grant […]
Contact
Maria R. Schimer
Chief Technology Transfer Officer
Phone: 330.325.6356
Email: maria@neomed.edu
Elliot Reed
Executive Director, NIICED
Phone: 330.325.6218
Email: ereed@neomed.edu
Office of Technology Transfer
Dr. Young recently received funding from @NSF for a project titled “Collaborative Research: Measuring leaping perfo… https://t.co/N2i3UZpZIM
Join NEOMED and @wkyc senior health correspondent, Monica Robins for the launch of its health care leadership speak… https://t.co/FprVFzXQxX
